| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |